NASHA_hyaluronic_acid_for_the_treatment_of_shoulder_osteoarthritis-1.jpg

Evaluate the efficacy, safety and tolerability of a single intra-articular injection of NASHA for the relief of pain over 26 weeks in patients with symptomatic GH-OA

NASHA hyaluronic acid for the treatment of shoulder osteoarthritis: a prospective, single-arm clinical trial.

Article specifications

This clinical trial was published in 2019 in Journal of Med Devices (IF 2018: 1.66) by Canadian specialists. This study was performed to evaluate the efficacy, safety and tolerability of a single intra-articular injection of NASHA for the relief of pain over 26 weeks in patients with symptomatic GH-OA.

 

Results

In conclusion, this study provides preliminary evidence that a single injection of NASHA may be efficacious in patients with symptomatic GH-OA. Improvements in pain were clinically and statistically significant and sustained over the 6-month follow-up period, and the primary study success criterion was met. NASHA appeared to be well tolerated, and no new safety signals were identified. Evidence from larger, controlled studies is needed to confirm these findings.

Tags: Canada Clinical trial 2019 Med Devices

Hayland Center

© 2018 HYLAND.CENTER ALL RIGHTS RESERVED